Clear Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Clear Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas [Phase 2]
Clinical trial BrUOG 354 assesses nivolumab with or without ipilimumab in ovarian and extrarenal (clear cell) carcinomas; the Phase 2 study …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) [Phase 2]
A three-arm Phase II clinical trial evaluates dostarlimab alone or with bevacizumab versus nonplatinum chemotherapy in recurrent gynecologic…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary Malignancies [Phase 2]
This clinical trial update reports on a Phase 2 study of XmAb20717 (Vudalimab) in selected advanced gynecologic and genitourinary cancers, w…
-
CLINICAL_TRIALS withdrawal · 2015-04-01Clinical Trial Update: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)
A clinical trial evaluating endometriosis and the frequency of endometriosis-associated ovarian carcinomas (endometrioid and clear cell type…